ArticleCancer research communications2022

Type-I interferon signaling is essential for robust metronomic chemo-immunogenic tumor regression in murine breast cancer.

Cameron Vergato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.